Abstract
We have designed and synthesized a small library of 3,5-disubstituted-1,2, 4-oxadiazole containing combretastatin A-4 (CA-4) analogs. Our objective is to increase the efficacy of the CA-4 as an anti-tubulin and antimitotic agent by substituting the cis-alkene bond with one of its bioisosteres, the 1,2,4-oxadiazole ring. We also modified the substituents attached to both of the phenyl rings (ring A and B in Fig. 1) of CA-4 for the purpose of diversifying our analogs based on SAR. These compounds were synthesized via a coupling reaction between an amidoxime and a carboxylic acid in DMF solvent, with HOBt as a base, and utilizing EDCI as a coupling reagent. Using this protocol, we synthesized a small library of 10 compounds with moderate to good yields. A detailed biological study is currently undergoing in our laboratory to evaluate the activity of these compounds.
| Original language | English |
|---|---|
| Pages (from-to) | 3947-3950 |
| Number of pages | 4 |
| Journal | Tetrahedron Letters |
| Volume | 53 |
| Issue number | 31 |
| DOIs | |
| State | Published - Aug 1 2012 |
Keywords
- 3,5-Disubstituted 1,2,4-oxadiazole
- Bioisosteres
- Boron-containing CA4 compound
- Combretastatin A-4
- Tubulin
- Vascular disrupting agent
Fingerprint
Dive into the research topics of 'Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver